Theresa W Gauthier1, David M Guidot2, Michael S Kelleman3, Courtney E McCracken3, Lou Ann S Brown3. 1. Department of Pediatrics, Emory University, Atlanta, Georgia. Electronic address: tgauthi@emory.edu. 2. Department of Medicine, Emory University, Atlanta, Georgia; Atlanta VA Medical Center, Decatur, Georgia. 3. Department of Pediatrics, Emory University, Atlanta, Georgia.
Abstract
BACKGROUND: We hypothesized that maternal alcohol use occurs in pregnancies that end prematurely and that in utero alcohol exposure is associated with an increased risk of morbidities of premature newborns. METHODS: In an observational study of mothers who delivered very low birth weight newborns (VLBW) ≤1,500 g, maternal alcohol use was determined via a standardized administered questionnaire. We compared the effect of maternal drinking on the odds of developing late-onset sepsis (LOS), bronchopulmonary dysplasia (BPD), death, BPD or death, days on oxygen or any morbidity (either LOS, BPD or death). The effect of drinking amounts (light versus heavy) was also evaluated. RESULTS: A total of 129 subjects who delivered 143 VLBW newborns were enrolled. Approximately 1 in 3 (34%) subjects reported drinking alcohol during the first trimester ("exposed"). Within the exposed group, 15% reported drinking ≥7drinks/week ("heavy") and 85% of the subjects reported drinking <7drinks/week ("light"). When controlling for maternal age, drug or tobacco use during pregnancy and neonatal gestational age, any drinking increased the odds of BPD or death and any morbidity. Furthermore, light or heavy drinking increased the odds of BPD or death and any morbidity, whereas heavy drinking increased the odds of LOS. CONCLUSIONS: In utero alcohol exposure during the first trimester occurred in 34% of VLBW newborns. Maternal drinking in the first trimester was associated with significantly increased odds of neonatal morbidity. Further studies are warranted to determine the full effect of in utero alcohol exposure on the adverse outcomes of VLBW premature newborns.
BACKGROUND: We hypothesized that maternal alcohol use occurs in pregnancies that end prematurely and that in utero alcohol exposure is associated with an increased risk of morbidities of premature newborns. METHODS: In an observational study of mothers who delivered very low birth weight newborns (VLBW) ≤1,500 g, maternal alcohol use was determined via a standardized administered questionnaire. We compared the effect of maternal drinking on the odds of developing late-onset sepsis (LOS), bronchopulmonary dysplasia (BPD), death, BPD or death, days on oxygen or any morbidity (either LOS, BPD or death). The effect of drinking amounts (light versus heavy) was also evaluated. RESULTS: A total of 129 subjects who delivered 143 VLBW newborns were enrolled. Approximately 1 in 3 (34%) subjects reported drinking alcohol during the first trimester ("exposed"). Within the exposed group, 15% reported drinking ≥7drinks/week ("heavy") and 85% of the subjects reported drinking <7drinks/week ("light"). When controlling for maternal age, drug or tobacco use during pregnancy and neonatal gestational age, any drinking increased the odds of BPD or death and any morbidity. Furthermore, light or heavy drinking increased the odds of BPD or death and any morbidity, whereas heavy drinking increased the odds of LOS. CONCLUSIONS: In utero alcohol exposure during the first trimester occurred in 34% of VLBW newborns. Maternal drinking in the first trimester was associated with significantly increased odds of neonatal morbidity. Further studies are warranted to determine the full effect of in utero alcohol exposure on the adverse outcomes of VLBW premature newborns.
Authors: Foula Sozo; Melissa Vela; Victoria Stokes; Kelly Kenna; Peter J Meikle; Robert De Matteo; David Walker; James Brien; Alan Bocking; Richard Harding Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-10-29 Impact factor: 5.464
Authors: Robert J Sokol; James J Janisse; Judette M Louis; Beth Nordstrom Bailey; Joel Ager; Sandra W Jacobson; Joseph L Jacobson Journal: Alcohol Clin Exp Res Date: 2007-03-31 Impact factor: 3.455
Authors: Mary K Ethen; Tunu A Ramadhani; Angela E Scheuerle; Mark A Canfield; Diego F Wyszynski; Charlotte M Druschel; Paul A Romitti Journal: Matern Child Health J Date: 2008-03-04
Authors: Irene Zelner; Kelly Kenna; James F Brien; Alan Bocking; Richard Harding; David Walker; Gideon Koren Journal: PLoS One Date: 2013-03-22 Impact factor: 3.240
Authors: Eva Aring; Emelie Gyllencreutz; Valdemar Landgren; Leif Svensson; Magnus Landgren; Marita Andersson Grönlund Journal: BMJ Open Ophthalmol Date: 2021-10-22